Pfizer Sees “Cadillac Tax” On Employer Plans Possibly Harming Rx Access
This article was originally published in The Pink Sheet Daily
Executive Summary
Affordable Care Act’s excise tax on employer health plans could lead employers to cut back on drug coverage, Pfizer policy director says; while the so-called “Cadillac tax” is supposed to be on high-premium plans, many fear the structure of the tax will cause low-cost plans to be subject to it as well.